Targeting Metabolic Heterogeneity in the Tumor Microenvironment: From Metabolic Plasticity to Therapeutic Vulnerability
Metabolic heterogeneity has emerged as a defining feature of cancer, yet its origins and therapeutic implications are often considered in a cancer cell-centric manner. Here, we summarize evidence that metabolic diversity is instead dynamically co-regulated by cancer cells, stromal and immune compartments, and by the abnormal vasculature within the tumor microenvironment (TME). We discuss how spatial and temporal fluctuations in oxygen and nutrient availability generate distinct metabolic niches that select for phenotypic plasticity and adaptive cell states. Across these niches, cancer cells differentially engage glycolysis, oxidative phosphorylation (OXPHOS), glutamine and lipid metabolism, and stress-response pathways, generating metabolic states associated with proliferation, survival, metastatic capacity, and therapy resistance. Particular attention is given to tumor endothelial cells (TECs), whose metabolic states influence vascular function and nutrient distribution and may thereby contribute to intratumoral metabolic heterogeneity. In parallel, oncogenic mutations, tissue context, and treatment-induced stress remodel pathway usage and foster the emergence of metabolically adaptable, stem-like, and drug-tolerant populations. Thus, cancer metabolic heterogeneity is shaped by cellular and environmental crosstalk rather than as a static consequence of genetic variation alone. This framework has important translational implications: effective metabolic therapies will require context-aware strategies that target specific niche liabilities while accounting for vascular state, immune function, and adaptive rewiring. Defining when and where these metabolic states create selective dependencies will be essential for translating metabolic heterogeneity into therapeutically actionable vulnerabilities.
Authors
- Alina Errerd (ORCID: https://orcid.org/0009-0003-8854-6189)
- Anna Rita Cantelmo (ORCID: https://orcid.org/0000-0002-2748-264X)
- Louay Bettaieb (ORCID: https://orcid.org/0000-0002-1680-7891)
- Evan Courmont (ORCID: https://orcid.org/0009-0008-5624-8933)
- Corina Birzoi (ORCID: https://orcid.org/0009-0002-8745-5974)
Publication Details
- Journal
- Cancer Biome and Targeted Therapy
- Published
- 2026-11-14
- DOI
- https://doi.org/10.66505/cbtt.v1i4.44
- Primary Topic
- Cancer, Hypoxia, and Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 0.00